PMC:7376974 / 92660-92957
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T439 | 22-35 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
T440 | 89-93 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T441 | 97-101 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T39 | 22-35 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1649 | 171-175 | Species | denotes | mice | Tax:10090 |
1650 | 234-238 | Species | denotes | mice | Tax:10090 |
1655 | 102-111 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T258 | 4-6 | Disease | denotes | NM | http://purl.obolibrary.org/obo/MONDO_0008091|http://purl.obolibrary.org/obo/MONDO_0011603 |
T260 | 102-111 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T849 | 22-35 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
T850 | 89-93 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T851 | 97-101 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T852 | 122-127 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T853 | 290-292 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T82326 | 4-6 | Chemical | denotes | NM | http://purl.obolibrary.org/obo/CHEBI_141423 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T557 | 0-297 | Sentence | denotes | The NM stimulated the immune system generating highly efficient antibodies able to block cell-to-cell infection of herpes virus in vivo (three intramuscular injections in mice every 14 days), increasing the survival rate of immunized mice to 100% against the controls (20% survival, Figure 18).153 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32667191-30594660-153409 | 294-297 | 30594660 | denotes | 153 |